Skip to main content
BTC / USDT107,400+2.19%ETH / USDT3,840+2.13%SOL / USDT182.40−1.99%BNB / USDT652.30+0.66%XRP / USDT2.2150+1.61%DOGE / USDT0.3850−1.79%TON / USDT5.240+2.34%AVAX / USDT42.60−2.07%LINK / USDT22.40+2.28%ADA / USDT1.0520−1.68%TRX / USDT0.3300+0.92%DOT / USDT8.420+2.93%BTC / USDT107,400+2.19%ETH / USDT3,840+2.13%SOL / USDT182.40−1.99%BNB / USDT652.30+0.66%XRP / USDT2.2150+1.61%DOGE / USDT0.3850−1.79%TON / USDT5.240+2.34%AVAX / USDT42.60−2.07%LINK / USDT22.40+2.28%ADA / USDT1.0520−1.68%TRX / USDT0.3300+0.92%DOT / USDT8.420+2.93%
Pricing
Get started→
stocksJul 29, 2026, 10:29 AM

GE Healthcare Tops Q2 Earnings Estimates, Reaffirms 2026 Outlook

GE Healthcare reported second-quarter adjusted EPS of $1.13, beating estimates, while revenue and adjusted EBIT also came in above consensus. The company reaffirmed its full-year 2026 guidance.

GEHC

GE Healthcare reported second-quarter 2026 results that exceeded analyst expectations. Adjusted earnings per share came in at $1.13, above the consensus estimate of $1.04. Adjusted EBIT reached $750 million, beating the expected $733.7 million, while revenue totaled $5.30 billion, slightly ahead of the $5.27 billion forecast.

The company also reaffirmed its full-year 2026 guidance. It continues to project adjusted EPS in the range of $4.80 to $5.00, compared to a consensus of $4.88. The adjusted margin is expected to be between 15.1% and 15.4%, in line with the midpoint estimate of 15.4%. Organic revenue growth is forecast at 3% to 4%, versus expectations of 3.66%.

With all key metrics above estimates and full-year targets confirmed, the results signal steady performance for the medical technology firm.

Source: First Squawk